Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1926
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals ; day:28 ; month:6 ; year:2016 ; pages:1-17
Clinical pharmacokinetics ; (28.6.2016), 1-17
- Creator
-
Schlender, Jan-Frederik
- Contributor
-
Meyer, Michaela
Thelen, Kirstin
Krauss, Markus
Willmann, Stefan
Eissing, Thomas
Jaehde, Ulrich
SpringerLink (Online service)
- DOI
-
10.1007/s40262-016-0422-3
- URN
-
urn:nbn:de:1111-201606309211
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schlender, Jan-Frederik
- Meyer, Michaela
- Thelen, Kirstin
- Krauss, Markus
- Willmann, Stefan
- Eissing, Thomas
- Jaehde, Ulrich
- SpringerLink (Online service)
Other Objects (12)
A whole-body mechanistic physiologically-based pharmacokinetic modeling of intravenous iron
Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals
A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life
Application of population, physiologically based, and semi-physiological pharmacokinetic modeling to assess sources of pharmacokinetic variability in individual drugs
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Using the LeiCNS-PK3.0 Physiologically-Based Pharmacokinetic Model to Predict Brain Extracellular Fluid Pharmacokinetics in Mice
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study
Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic Approach
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Adapting physiologically-based pharmacokinetic models for machine learning applications
A whole-body mechanistic physiologically-based pharmacokinetic modeling of intravenous iron
Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals
A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life
Application of population, physiologically based, and semi-physiological pharmacokinetic modeling to assess sources of pharmacokinetic variability in individual drugs
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Using the LeiCNS-PK3.0 Physiologically-Based Pharmacokinetic Model to Predict Brain Extracellular Fluid Pharmacokinetics in Mice
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study
Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic Approach
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Adapting physiologically-based pharmacokinetic models for machine learning applications
A whole-body mechanistic physiologically-based pharmacokinetic modeling of intravenous iron
Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals
A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life
Application of population, physiologically based, and semi-physiological pharmacokinetic modeling to assess sources of pharmacokinetic variability in individual drugs
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Using the LeiCNS-PK3.0 Physiologically-Based Pharmacokinetic Model to Predict Brain Extracellular Fluid Pharmacokinetics in Mice
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study
Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic Approach
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling